Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-14

Clinical Trial Update: ACEI/CCB Versus ACEI/DIU Combination Antihypertensive Therapy in Chinese Hypertensive Patients (ACvAD) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ACE inhibitor/ calcium channel blocker versus ACE inhibitor/ diuretic combination antihypertensive therapy in Chinese patients with hype…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACE inhibitor/ calcium channel blocker combination
  • ACE inhibitor/ diuretic combination

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Hypertension | Phase 4 | Status: COMPLETED